The interactome of LIM domain proteins: The contributions of LIM domain proteins to heart failure and heart development

Proteomics

Volumn 12, Issue 2, 2012, Pages 203-225

  Li, Amy ^a   Ponten, Fredrik ^b   dos Remedios, Cristobal G ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Bioinformatics; Heart development; Heart failure; Interactome; LIM domain proteins; Multi protein complex

Indexed keywords

ACTIN BINDING LIM 3 PROTEIN; ATRIAL NATRIURETIC FACTOR; CYSTEINE; DYXIN; F BOX ONLY PROTEIN 20; F BOX PROTEIN; FOUR AND A HALF LIM DOMAINS PROTEIN 1; FOUR AND A HALF LIM DOMAINS PROTEIN 2; GLYCINE RICH PROTEIN 1; GLYCINE RICH PROTEIN 2; HYDROGEN PEROXIDE INDUCIBLE CLONE 5 PROTEIN; INSULIN GENE ENHANCER PROTEIN 1; LIM DOMAIN BINDING PROTEIN 3; LIM DOMAIN PROTEIN 5; LIM DOMAIN PROTEIN 7; LIM HOMEOBOX PROTEIN 9; LIM KINASE 1; LIM KINASE 2; LIM PROTEIN; MIGFILIN; MUSCLE LIM PROTEIN; NEBULIN; NEBULIN RELATED ANCHORING PROTEIN; PAXILLIN; PDZ PROTEIN; PROTEIN SH3; RHOMBOTIN 2; THYMOSIN BETA4; UNCLASSIFIED DRUG; ZYXIN; ZYXIN RELATED PROTEIN 1;

AMINO ACID SEQUENCE; CARDIOMYOPATHY; CORONARY BLOOD VESSEL; GENE EXPRESSION; HEART; HEART DEVELOPMENT; HEART DISEASE; HEART FAILURE; HEART MUSCLE; HEART OUTPUT; HISTORY; HUMAN; MEDLINE; MUTATION; NONHUMAN; PDZ DOMAIN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN LOCALIZATION; REVIEW;

ANIMALS; CELL DIFFERENTIATION; HEART; HEART FAILURE; HUMANS; LIM DOMAIN PROTEINS; MAMMALS; MULTIPROTEIN COMPLEXES; MYOCARDIUM; MYOCYTES, CARDIAC; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; ZINC FINGERS;

MAMMALIA;

EID: 84855981967     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100492     Document Type: Review

References (193)

1. Freyd, G., Kim, S. K., Horvitz, H. R., Novel cysteine-rich motif and homeodomain in the product of the Caenorhabditis elegans cell lineage gene lin-II. Nature 1990, 344, 876-879.
2. Dawid, I. B., Breen, J., Toyama, R., LIM domains: Multiple roles as adapters and functional modifiers in protein interactions. Trends Genet. 1998, 14, 56-62.
3. Zheng, Q., Zhao, Y., The diverse biofunctions of LIM domain proteins: determined by subcellular localization and protein-protein interaction. Biol. Cell 2007, 099, 489-502.
4. Kadrmas, J. L., Beckerle, M. C., The LIM domain: From the cytoskeleton to the nucleus. Nat. Rev. Mol. Cell. Biol. 2004, 5, 920-931.
5. Michelsen, J. W., Sewell, A. K., Louis, H. A., Olsen, J. I. et al., Mutational analysis of the metal sites in an Lim domain. J. Biol. Chem. 1994, 269, 11108-11113.
6. Sanchezgarcia, I., Osada, H., Forster, A., Rabbitts, T. H., The cysteine-rich Lim domains inhibit DNA-binding by the associated homeodomain in Isl-1. EMBO J. 1993, 12, 4243-4250.
7. Xue, D., Tu, Y., Chalfie, M., Cooperative interactions between the Caenorhabditis elegans homeoproteins Unc-86 and Mec-3. Science 1993, 261, 1324-1328.
8. Khurana, T., Khurana, B., Noegel, A. A., LIM proteins: Association with the actin cytoskeleton. Protoplasma 2002, 219, 1-12.
9. Consortium, T. U., Ongoing and future developments at the Universal Protein Resource. Nucleic Acid Res. 2011, 39, D214-D219.
10. Mohiddin, S. A., Lu, S., Cardoso, J.-P., Carroll, S. et al., Genomic organization, alternative splicing, and expression of human and mouse N-RAP, a nebulin-related LIM protein of striated muscle. Cell Motil. Cytoskeleton 2003, 55, 200-212.
11. Ehler, E., Horowits, R., Zuppinger, C., Price, R. L. et al., Alterations at the intercalated disk associated with the absence of muscle Lim protein. J. Cell Biol. 2001, 153, 763-772.
12. Zhang, J. Q., Elzey, B., Williams, G., Lu, S. et al., Ultrastructural and biochemical localization of N-RAP at the interface between myofibrils and intercalated disks in the mouse heart. Biochemistry 2001, 40, 14898-14906.
13. Crawford, G., Horowits, R., Scaffolds and chaperones in myofibril assembly: putting the striations in striated muscle. Biophys. Rev. 2011, 3, 25-32.
14. Lu, S., Horowits, R., Role of nonmuscle myosin IIB and N-RAP in cell spreading and myofibril assembly in primary mouse cardiomyocytes. Cell Motil. Cytoskeleton 2008, 65, 747-761.
15. Lu, S., Carroll, S. L., Herrera, A. H., Ozanne, B., Horowits, R., New N-RAP-binding partners α-actinin, filamin and Krp1 detected by yeast two-hybrid screening: implications for myofibril assembly. J. Cell Sci. 2003, 116, 2169-2178.
16. Carroll, S., Lu, S., Herrera, A. H., Horowits, R., N-RAP scaffolds I-Z-I assembly during myofibrillogenesis in cultured chick cardiomyocytes. J. Cell Sci. 2004, 117, 105-114.
17. Perriard, J.-C., Hirschy, A., Ehler, E., Dilated cardiomyopathy: a disease of the intercalated disc? Trends Cardiovasc. Med. 2003, 13, 30-38.
18. Lu, S., Crawford, G. L., Dore, J., Anderson, S. A. et al., Cardiac-specific NRAP overexpression causes right ventricular dysfunction in mice. Exp. Cell Res. 2011, 317, 1226-1237.
19. Moncman, C. L., Wang, K., Nebulette: a 107kD nebulin-like protein in cardiac muscle. Cell Motil. Cytoskeleton 1995, 32, 205-225.
20. Li, B., Zhuang, L., Trueb, B., Zyxin interacts with the SH3 domains of the cytoskeletal proteins LIM-nebulette and Lasp-1. J. Biol. Chem. 2004, 279, 20401-20410.
21. Zieseniss, A., Terasaki, A. G., Gregorio, C. C., Lasp-2 expression, localization, and ligand interactions: a new Z-disc scaffolding protein. Cell Motil. Cytoskeleton 2008, 65, 59-72.
22. Moncman, C. L., Wang, K., Targeted disruption of nebulette protein expression alters cardiac myofibril assembly and function. Exp. Cell Res. 2002, 273, 204-218.
23. Bonzo, J. R., Norris, A. A., Esham, M., Moncman, C. L., The nebulette repeat domain is necessary for proper maintenance of tropomyosin with the cardiac sarcomere. Exp. Cell Res. 2008, 314, 3519-3530.
24. Moncman, C. L., Wang, K., Functional dissection of nebulette demonstrates actin binding of nebulin-like repeats and Z-line targeting of SH3 and linker domains. Cell Motil. Cytoskeleton 1999, 44, 1-22.
25. Purevjav, E., Varela, J., Morgado, M., Kearney, D. L. et al., Nebulette mutations are associated with dilated cardiomyopathy and endocardial fibroelastosis. J. Am. Coll. Cardiol. 2010, 56, 1493-1502.
26. Ram, R., Blaxall, B. C., Nebulette mutations in cardiac remodeling: big effects from a small mechanosensor. J. Am. Coll. Cardiol. 2010, 56, 1503-1505.
27. Moncman, C. L., Panaviene, Z., Linker region of nebulin family members plays an important role in targeting these molecules to cellular structures. Cell Tissue Res. 2007, 327, 353-369.
28. Chew, C. S., Chen, X., Parente, J. A., Tarrer, S. et al., Lasp-1 binds to non-muscle F-actin in vitro and is localized within multiple sites of dynamic actin assembly in vivo. J. Cell Sci. 2002, 115, 4787-4799.
29. Panaviene, Z., Moncman, C., Linker region of nebulin family members plays an important role in targeting these molecules to cellular structures. Cell Tissue Res. 2007, 327, 353-369.
30. Uhlen, M., Oksvold, P., Fagerberg, L., Lundberg, E. et al., Towards a knowledge-based human protein atlas. Nat. Biotechnol. 2010, 28, 1248-1250.
31. Holaska, J. M., Rais-Bahrami, S., Wilson, K. L., Lmo7 is an emerin-binding protein that regulates the transcription of emerin and many other muscle-relevant genes. Human Mol. Genetics 2006, 15, 3459-3472.
32. Ott, E. B., van den Akker, N. M. S., Sakalis, P. A., Gittenberger-de Groot, A. C. et al., The lim domain only protein 7 is important in zebrafish heart development. Dev. Dynam. 2008, 237, 3940-3952.
33. Semenova, E., Wang, X., Jablonski, M. M., Levorse, J., Tilghman, S. M., An engineered 800 kilobase deletion of Uchl3 and Lmo7 on mouse chromosome 14 causes defects in viability, postnatal growth and degeneration of muscle and retina. Human Mol. Genetics 2003, 12, 1301-1312.
34. Milan, D. J., Giokas, A. C., Serluca, F. C., Peterson, R. T., MacRae, C. A., Notch1b and neuregulin are required for specification of central cardiac conduction tissue. Development 2006, 133, 1125-1132.
35. Holaska, J. M., Emerin and the nuclear lamina in muscle and cardiac disease. Circ. Res. 2008, 103, 16-23.
36. Kotaka, M., Ngai, S.-M., Garcia-Barcelo, M., Tsui, S. K. W. et al., Characterization of the human 36-kDa carboxyl terminal LIM domain protein (hCLIM1). J. Cell. Biochem. 1999, 72, 279-285.
37. Kotaka, M., Kostin, S., Ngai, S.-M., Chan, K.-K. et al., Interaction of hCLIM1, an Enigma family protein, with α-actinin 2. J. Cell. Biochem. 2000, 78, 558-565.
38. Kotaka, M., Lau, Y.-M., Cheung, K.-K., Lee, S. M. Y. et al., Elfin is expressed during early heart development. J. Cell. Biochem. 2001, 83, 463-472.
39. Arber, S., Halder, G., Caroni, P., Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation. Cell 1994, 79, 221-231.
40. Zimmermann, R., Kostin, S., Kotaka, M., Waye, M. M. et al., A possible role for novel LIM domain proteins in dilated cardiomyopathy. Circulation 1999, 100, 565-565.
41. Pashmforoush, M., Pomies, P., Peterson, K. L., Kubalak, S. et al., Adult mice deficient in actinin-associated LIM-domain protein reveal a developmental pathway for right ventricular cardiomyopathy. Nat. Med. 2001, 7, 591-597.
42. Arola, A. M., Sanchez, X., Murphy, R. T., Hasle, E. et al., Mutations in PDLIM3 and MYOZ1 encoding myocyte Z line proteins are infrequently found in idiopathic dilated cardiomyopathy. Mol. Genet. Metab. 2007, 90, 435-440.
43. Bagnall, R. D., Yeates, L., Semsarian, C., Analysis of the Z-disc genes PDLIM3 and MYPN in patients with hypertrophic cardiomyopathy. Int. J. Cardiol. 2010, 145, 601-602.
44. Olson, E. N., Gene regulatory networks in the evolution and development of the heart. Science 2006, 313, 1922-1927.
45. Cai, C. L., Liang, X., Shi, Y., Chu, P. H. et al., Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev. Cell 2003, 5, 877-889.
46. Dodou, E., Verzi, M. P., Anderson, J. P., Xu, S.-M., Black, B. L., Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. Development 2004, 131, 3931-3942.
47. Bu, L., Jiang, X., Martin-Puig, S., Caron, L. et al., Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 2009, 460, 113-117.
48. Laugwitz, K.-L., Moretti, A., Lam, J., Gruber, P. et al., Postnatal isl1+cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005, 433, 647-653.
49. Moretti, A., Lam, J., Evans, S., Laugwitz, K., Cardiovascular development: towards biomedical applicability. Cell. Mol. Life Sci. 2007, 64, 674-682.
50. Barzelay, A., Ben-Shoshan, J., Entin-Meer, M., Maysel-Auslender, S. et al., A potential role for islet-1 in post-natal angiogenesis and vasculogenesis. Thromb. Haemost. 2010, 103, 188-197.
51. Pouly, J., Bruneval, P., Mandet, C., Proksch, S. et al., Cardiac stem cells in the real world. J. Thorac. Cardiovasc. Surg. 2008, 135, 673-678.
52. Khattar, P., Friedrich, F. W., Bonne, G., Carrier, L. et al., Distinction between two populations of islet-1-positive cells in hearts of different murine strains. Stem Cells Dev. 2011, 20, 1043-1052.
53. Henderson, J. R., Macalma, T., Brown, D., Richardson, J. A. et al., The LIM protein, CRP1, is a smooth muscle marker. Dev. Dynam. 1999, 214, 229-238.
54. Beckerle, M. C., Schmeichel, K. L., LIM domains of cysteine-rich protein 1 (CRP1) are essential for its zyxin-binding function. Biochem. J. 1998, 331, 885-892.
55. Tran, T. C., Singleton, C., Fraley, T. S., Greenwood, J. A., Cysteine-rich protein 1 (CRP1) regulates actin filament bundling. BMC Cell Biol 2005, 6, 45.
56. Ogura, T., Miyasaka, K. Y., Kida, Y. S., Sato, T., Minarni, M., Csrp1 regulates dynamic cell movements of the mesendoderm and cardiac mesoderm through interactions with Dishevelled and Diversin. Proc. Natl. Acad. Sci. USA 2007, 104, 11274-11279.
57. Chang, D. F., Belaguli, N. S., Iyer, D., Roberts, W. B. et al., Cysteine-rich LIM-only proteins CRP1 and CRP2 are potent smooth muscle differentiation cofactors. Dev. Cell 2003, 4, 107-118.
58. Weiskirchen, R., Pino, J. D., Macalma, T., Bister, K., Beckerle, M. C., The cysteine-rich protein family of highly related LIM domain proteins. J. Biol. Chem. 1995, 270, 28946-28954.
59. Sagave, J., Moser, M., Ehler, E., Weiskirchen, S. et al., Targeted disruption of the mouse Csrp2 gene encoding the cysteine- and glycine-rich LIM domain protein CRP2 result in subtle alteration of cardiac ultrastructure. BMC Dev. Biol. 2008, 8, 80.
60. Henderson, J. R., Brown, D., Richardson, J. A., Olson, E. N., Beckerle, M. C., Expression of the gene encoding the LIM protein CRP2: a developmental profile. J. Histochem. Cytochem. 2002, 50, 107-111.
61. Jain, M. K., Fujita, K. P., Hsieh, C.-M., Endege, W. O. et al., Molecular cloning and characterization of SmLIM, a developmentally regulated LIM protein preferentially expressed in aortic smooth muscle cells. J. Biol. Chem. 1996, 271, 10194-10199.
62. Jain, M. K., Kashiki, S., Hsieh, C.-M., Layne, M. D. et al., Embryonic expression suggests an important role for CRP2/SmLIM in the developing cardiovascular system. Circ. Res. 1998, 83, 980-985.
63. Wei, T.-C., Lin, H.-Y., Lu, C.-C., Chen, C.-M., You, L.-R., Expression of Crip2, a LIM-domain-only protein, in the mouse cardiovascular system under physiological and pathological conditions. Gene Expr. Patterns. 2011, 11, 384-394.
64. Zheng, B., Wen, J.-K., Han, M., Zhou, A.-R., hhLIM protein is involved in cardiac hypertrophy. Biochim. Biophys. Acta (BBA) - Mol. Basis Dis. 2004, 1690, 1-10.
65. Zheng, B., Wen, J.-K., Han, M., hhLIM is a novel F-actin binding protein involved in actin cytoskeleton remodeling. FEBS J. 2008, 275, 1568-1578.
66. Zheng, B., Han, M., Wen, J.-K., Human heart LIM protein has transcription activation ability related to LIM domain 1. Biochemistry (Moscow) 2008, 73, 353-357.
67. Zheng, B., Han, M., Wen, J.-K., Zhang, R., Human heart LIM protein activates atrial-natriuretic-factor gene expression by interacting with the cardiac-restricted transcription factor Nkx2. 5. Biochem. J. 2008, 409, 683-690.
68. Zheng, B., Wen, J.-K., Han, M., hhLIM is involved in cardiomyogenesis of embryonic stem cells. Biochemistry (Moscow) 2006, 71, S71-S76.
69. Yu, T.-S., Moctezuma-Anaya, M., Kubo, A., Keller, G., Robertson, S., The heart LIM protein gene (Hlp), expressed in the developing and adult heart, defines a new tissue-specific LIM-only protein family. Mech. Dev. 2002, 116, 187-192.
70. Caroni, P., Arber, S., Barbayannis, F. A., Hanser, H. et al., Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 1998, 393, 805-809.
71. Lindstrom, N. O. L. N. O., Neves, C., McIntosh, R., Miedzybrodzka, Z. et al., Tissue specific characterisation of Lim-kinase 1 expression during mouse embryogenesis. Gene Expr. Patterns 2011, 11, 221-232.
72. Lin, G., Craig, G. P., Zhang, L., Yuen, V. G. et al., Acute inhibition of Rho-kinase improves cardiac contractile function in streptozotocin-diabetic rats. Cardiovasc. Res. 2007, 75, 51-58.
73. Davani, E. Y., Dorscheid, D. R., Lee, C.-H., van Breemen, C., Walley, K. R., Novel regulatory mechanism of cardiomyocyte contractility involving ICAM-1 and the cytoskeleton. Am. J. Physiol. - Heart Circ. Physiol. 2004, 287, H1013-H1022.
74. Frank, D., Frauen, R., Hanselmann, C., Kuhn, C. et al., Lmcd1/Dyxin, a novel Z-disc associated LIM protein, mediates cardiac hypertrophy in vitro and in vivo. J. Mol. Cell. Cardiol. 2010, 49, 673-682.
75. Bian, Z.-Y., Huang, H., Jiang, H., Shen, D.-F. et al., LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling. Hypertension 2010, 55, 257-263.
76. Akazawa, H., Komuro, I., Roles of cardiac transcription factors in cardiac hypertrophy. Circ. Res. 2003, 92, 1079-1088.
77. Oka, T., Xu, J., Molkentin, J. D., Re-employment of developmental transcription factors in adult heart disease. Semin. Cell Dev. Biol. 2007, 18, 117-131.
78. Luosujärvi, H., Aro, J., Tokola, H., Leskinen, H. et al., A novel p38 MAPK target dyxin is rapidly induced by mechanical load in the heart. Blood Pressure 2010, 19, 54-63.
79. Zolk, O., Caroni, P., Bohm, M., Decreased expression of the cardiac LIM domain protein MLP in chronic human heart failure. Circulation 2000, 101, 2674-2677.
80. Boateng, S. Y., Senyo, S. E., Qi, L., Goldspink, P. H., Russell, B., Myocyte remodeling in response to hypertrophic stimuli requires nucleocytoplasmic shuttling of muscle LIM protein. J. Mol. Cell. Cardiol. 2009, 47, 426-435.
81. Wiersma, A. C., Stabej, P., Leegwater, P. A. J., Van Oost, B. A. et al., Evaluation of 15 candidate genes for dilated cardiomyopathy in the newfoundland dog. J. Hered. 2008, 99, 73-80.
82. Lorenzen-Schmidt, I., Stuyvers, B. D., ter Keurs, H. E. D. J., Date, M.-O. et al., Young MLP deficient mice show diastolic dysfunction before the onset of dilated cardiomyopathy. J. Mol. Cell. Cardiol. 2005, 39, 241-250.
83. Estigoy, C., Pontén, F., Odeberg, J., Herbert, B. et al., Intercalated discs: multiple proteins perform multiple functions in non-failing and failing human hearts. Biophys. Rev. 2009, 1, 43-49.
84. Russell, B., Curtis, M. W., Koshman, Y. E., Samarel, A. M., Mechanical stress-induced sarcomere assembly for cardiac muscle growth in length and width. J. Mol. Cell. Cardiol. 2010, 48, 817-823.
85. Chang, A., Potter, J., Sarcomeric protein mutations in dilated cardiomyopathy. Heart Failure Rev. 2005, 10, 225-235.
86. Knöll, R., Hoshijima, M., Hoffman, H. M., Person, V. et al., The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 2002, 111, 943-955.
87. Buyandelger, B., Ng, K.-E., Miocic, S., Piotrowska, I. et al., MLP (muscle LIM protein) as a stress sensor in the heart. Pflug. Arch. 2011, 462, 135-142.
88. Knoll, R., Kostin, S., Klede, S., Savvatis, K. et al., A common MLP (muscle LIM protein) variant is associated with cardiomyopathy. Circ. Res. 2010, 106, 695-704.
89. Geier, C., Perrot, A., Özcelik, C., Binner, P. et al., Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation 2003, 107, 1390-1395.
90. Geier, C., Gehmlich, K., Ehler, E., Hassfeld, S. et al., Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy. Human Mol. Genet. 2008, 17, 2753-2765.
91. Gehmlich, K., Geier, C., Osterziel, K. J., Van der Ven, P. F. M., Fürst, D. O., Decreased interactions of mutant muscle LIM protein (MLP) with N-RAP and α-actinin and their implication for hypertrophic cardiomyopathy. Cell Tissue Res. 2004, 317, 129-136.
92. Arber, S., Hunter, J. J., Ross, J., Jr., Hongo, M. et al., MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 1997, 88, 393-403.
93. Gunkel, S., Heineke, J., Hilfiker-Kleiner, D., Knöll, R., MLP: A stress sensor goes nuclear. J. Mol. Cell. Cardiol. 2009, 47, 423-425.
94. Geiger, B., Spatz, J. P., Bershadsky, A. D., Environmental sensing through focal adhesions. Nat. Rev. Mol. Cell. Biol. 2009, 10, 21-33.
95. Gehmlich, K., Ehler, E., Perrot, A., Fürst, D. O., Geier, C., "MLP: a stress sensor goes nuclear" By Sylvia Gunkel, Jörg Heineke, Denise Hilfiker-Kleiner, Ralph Knöll, J. Mol. Cell. Cardiol. 2009, 47, 423-425. J. Mol. Cell. Cardiol. 2010, 48, 424-425.
96. Voelkel, T., Linke, W. A., Conformation-regulated mechanosensory control via titin domains in cardiac muscle. Pflug. Arch. 2011, 462, 143-154.
97. Smagulova, F., Manuylov, N., Leach, L., Tevosian, S., GATA4/FOG2 transcriptional complex regulates Lhx9 gene expression in murine heart development. BMC Dev. Biol. 2008, 8, 67.
98. Yamada, Y., Pannell, R., Forster, A., Rabbitts, T. H., The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. Proc. Natl. Acad. Sci. USA 2000, 97, 320-324.
99. Moik, D. V., Janbandhu, V. C., Fässler, R., Loss of migfilin expression has no overt consequences on murine development and homeostasis. J. Cell Sci. 2011, 124, 414-421.
100. Dowling, J. J., Gibbs, E., Russell, M., Goldman, D. et al., Kindlin-2 is an essential component of intercalated discs and is required for vertebrate cardiac structure and function. Circ. Res. 2008, 102, 423-431.
101. Hatcher, C. J., Basson, C. T., Disrupted intercalated discs. Circ. Res. 2008, 102, 392-394.
102. Wu, C., Migfilin and its binding partners: from cell biology to human diseases. J. Cell Sci. 2005, 118, 659-664.
103. Akazawa, H., Kudoh, S., Mochizuki, N., Takekoshi, N. et al., A novel LIM protein Cal promotes cardiac differentiation by association with CSX/NKX2-5. J. Cell Biol. 2004, 164, 395-405.
104. Brancaccio, M., Hirsch, E., Notte, A., Selvetella, G. et al., Integrin signalling: the tug-of-war in heart hypertrophy. Cardiovasc. Res. 2006, 70, 422-433.
105. Schott, J.-J., Benson, D. W., Basson, C. T., Pease, W. et al., Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998, 281, 108-111.
106. Thompson, J. T., Rackley, M. S., O'Brien, T. X., Upregulation of the cardiac homeobox gene Nkx2-5 (CSX) in feline right ventricular pressure overload. Am. J. Physiol. - Heart Circ. Physiol. 1998, 274, H1569-H1573.
107. Yamazaki, T., Wälchli, S., Fujita, T., Ryser, S. et al., Splice variants of Enigma homolog, differentially expressed during heart development, promote or prevent hypertrophy. Cardiovasc. Res. 2010, 86, 374-382.
108. Wang, X., Su, H., Unraveling Enigma in the Z-disks. Circ. Res. 2010, 107, 321-323.
109. Maturana, A. D., Nakagawa, N., Yoshimoto, N., Tatematsu, K. et al., LIM domains regulate protein kinase C activity: A novel molecular function. Cell. Signal. 2011, 23, 928-934.
110. Hoshijima, M., Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures. Am. J. Physiol. - Heart Circ. Physiol. 2006, 290, H1313-H1325.
111. Maturana, A. D., Walchli, S., Iwata, M., Ryser, S. et al., Enigma homolog 1 scaffolds protein kinase D1 to regulate the activity of the cardiac L-type voltage-gated calcium channel. Cardiovasc. Res. 2008, 78, 458-465.
112. Cheng, H., Kimura, K., Peter, A. K., Cui, L. et al., Loss of Enigma homolog protein results in dilated cardiomyopathy/novelty and significance. Circ. Res. 2010, 107, 348-356.
113. Bimber, B., Dettman, R. W., Simon, H.-G., Differential regulation of Tbx5 protein expression and sub-cellular localization during heart development. Dev. Biol. 2007, 302, 230-242.
114. Camarata, T., Krcmery, J., Snyder, D., Park, S. et al., Pdlim7 (LMP4) regulation of Tbx5 specifies zebrafish heart atrio-ventricular boundary and valve formation. Dev. Biol. 2010, 337, 233-245.
115. Shimojo, M., Hersh, L. B., REST/NRSF-interacting LIM domain protein, a putative nuclear translocation receptor. Mol. Cell. Biol. 2003, 23, 9025-9031.
116. Maurer-Stroh, S., Eisenhaber, F., Refinement and prediction of protein prenylation motifs. Genome Biol. 2005, 6, R55.
117. Shimojo, M., Hersh, L. B., Characterization of the REST/NRSF-interacting LIM domain protein (RILP): localization and interaction with REST/NRSF. J. Neurochem. 2006, 96, 1130-1138.
118. Cameron, V. A., Ellmers, L. J., Minireview: Natriuretic peptides during development of the fetal heart and circulation. Endocrinology 2003, 144, 2191-2194.
119. Shimojo, M., RE1-silencing transcription factor (REST) and REST-interacting LIM domain protein (RILP) affect P19CL6 differentiation. Genes Cells 2011, 16, 90-100.
120. Faulkner, G., Pallavicini, A., Formentin, E., Comelli, A. et al., ZASP: a new Z-band alternatively spliced PDZ-motif protein. J. Cell Biol. 1999, 146, 465-475.
121. Klaavuniemi, T., Ylänne, J., Zasp/Cypher internal ZM-motif containing fragments are sufficient to co-localize with [α]-actinin - analysis of patient mutations. Exp. Cell Res. 2006, 312, 1299-1311.
122. Zhou, Q., Chu, P.-H., Huang, C., Cheng, C.-F. et al., Ablation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy. J. Cell Biol. 2001, 155, 605-612.
123. Vatta, M., Mohapatra, B., Jimenez, S., Sanchez, X. et al., Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J. Am. Coll. Cardiol. 2003, 42, 2014-2027.
124. Arimura, T., Hayashi, T., Terada, H., Lee, S.-Y. et al., A Cypher/ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C. J. Biol. Chem. 2004, 279, 6746-6752.
125. Li, B., Zhuang, L., Trueb, B., Zyxin interacts with the SH3 domains of the cytoskeletal proteins LIM-nebulette and Lasp-1. J. Biol. Chem. 2004, 279, 20401-20410.
126. Mori, M., Nakagami, H., Koibuchi, N., Miura, K. et al., Zyxin mediates actin fiber reorganization in epithelial-mesenchymal transition and contributes to endocardial morphogenesis. Mol. Biol. Cell 2009, 20, 3115-3124.
127. Kato, T., Muraski, J., Chen, Y., Tsujita, Y. et al., Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt. J. Clin. Invest. 2005, 115, 2716-2730.
128. Cattaruzza, M., Lattrich, C., Hecker, M., Focal adhesion protein Zyxin is a mechanosensitive modulator of gene expression in vascular smooth muscle cells. Hypertension 2004, 43, 726-730.
129. Nix, D. A., Beckerle, M. C., Nuclear-cytoplasmic shuttling of the focal contact protein, Zyxin: a potential mechanism for communication between sites of cell adhesion and the nucleus. J. Cell Biol. 1997, 138, 1139-1147.
130. Rosenkranz, A. C., Woods, R. L., Dusting, G. J., Ritchie, R. H., Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: Importance of cyclic GMP. Cardiovasc. Res. 2003, 57, 515-522.
131. Wang, Y., Gilmore, T. D., LIM domain protein Trip6 has a conserved nuclear export signal, nuclear targeting sequences, and multiple transactivation domains. Biochim. Biophys. Acta 2001, 1538, 260-272.
132. Roof, D. J., Hayes, A., Adamian, M., Chishti, A. H., Li, T., Molecular characterization of abLIM, a novel actin-binding and double zinc finger protein. J. Cell Biol. 1997, 138, 575-588.
133. Krupp, M., Weinmann, A., Galle, P. R., Teufel, A., Actin binding LIM protein 3 (abLIM3). Int. J. Mol. Med. 2006, 17, 129-133.
134. Barrientos, T., Frank, D., Kuwahara, K., Bezprozvannaya, S. et al., Two novel members of the ABLIM protein family, ABLIM-2 and -3, associate with STARS and directly bind F-actin. J. Biol. Chem. 2007, 282, 8393-8403.
135. Zheng, B., Han, M., Bernier, M., Wen, J.-K., Nuclear actin and actin-binding proteins in the regulation of transcription and gene expression. FEBS J. 2009, 276, 2669-2685.
136. Geiger, B., Bershadsky, A., Exploring the neighborhood: adhesion-coupled cell mechanosensors. Cell 2002, 110, 139-142.
137. Mahadeva, H., Brooks, G., Lodwick, D., Chong, N. W., Samani, N. J., MS1, a novel stress-responsive, muscle-specific gene that is up-regulated in the early stages of pressure overload-induced left ventricular hypertrophy. FEBS Lett. 2002, 521, 100-104.
138. Gehmlich, K., Pinotsis, N., Hayeß, K., van der Ven, P. F. M. et al., Paxillin and ponsin interact in nascent costameres of muscle cells. J. Mol. Biol. 2007, 369, 665-682.
139. Hagel, M., George, E. L., Kim, A., Tamimi, R. et al., The adaptor protein paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling. Mol. Cell. Biol. 2002, 22, 901-915.
140. Melendez, J., Turner, C., Avraham, H., Steinberg, S. F. et al., Cardiomyocyte apoptosis triggered by RAFTK/pyk2 via Src kinase is antagonized by paxillin. J. Biol. Chem. 2004, 279, 53516-53523.
141. Brown, M. C., Perrotta, J. A., Turner, C. E., Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding. J. Cell Biol. 1996, 135, 1109-1123.
142. Yuminamochi, T., Yatomi, Y., Osada, M., Ohmori, T. et al., Expression of the LIM proteins paxillin and Hic-5 in human tissues. J. Histochem. Cytochem. 2003, 51, 513-521.
143. Yund, E. E., Hill, J. A., Keller, R. S., Hic-5 is required for fetal gene expression and cytoskeletal organization of neonatal cardiac myocytes. J. Mol. Cell. Cardiol. 2009, 47, 520-527.
144. Cowling, B. S., Cottle, D. L., Wilding, B. R., D'Arcy, C. E. et al., Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features. Neuromusc. Disord. 2011, 21, 237-251.
145. Yang, Z., Browning, C. F., Hallaq, H., Yermalitskaya, L. et al., Four and a half LIM protein 1: a partner for KCNA5 in human atrium. Cardiovasc. Res. 2008, 78, 449-457.
146. Dobrev, D., Wettwer, E., Four and a half LIM protein 1: A novel chaperone for atrium-specific Kv1. 5 channels with a potential role in atrial arrhythmogenesis. Cardiovasc. Res. 2008, 78, 411-412.
147. Brown, S., McGrath, M. J., Ooms, L. M., Gurung, R. et al., Characterization of Two Isoforms of the Skeletal Muscle LIM Protein 1, SLIM1. J. Biol. Chem. 1999, 274, 27083-27091.
148. Bach, I., The LIM domain: Regulation by association. Mech. Dev. 2000, 91, 5-17.
149. Ng, E. K. O., Lee, S. M. Y., Li, H.-Y., Ngai, S.-M. et al., Characterization of tissue-specific LIM domain protein (FHL1C) which is an alternatively spliced isoform of a human LIM-only protein (FHL1). J. Cell. Biochem. 2001, 82, 1-10.
150. Chu, P.-H., Ruiz-Lozano, P., Zhou, Q., Cai, C., Chen, J., Expression patterns of FHL/SLIM family members suggest important functional roles in skeletal muscle and cardiovascular system. Mech. Dev. 2000, 95, 259-265.
151. Gramolini, A. O., Kislinger, T., Alikhani-Koopaei, R., Fong, V. et al., Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses. Mol. Cell Proteomics 2008, 7, 519-533.
152. Yang, J., Moravec, C. S., Sussman, M. A., DiPaola, N. R. et al., Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation 2000, 102, 3046-3052.
153. Shathasivam, T., Kislinger, T., Gramolini, A. O., Genes, proteins and complexes: the multifaceted nature of FHL family proteins in diverse tissues. J. Cell Mol. Med. 2010, 14, 2702-2720.
154. Knoblauch, H., Geier, C., Adams, S., Budde, B. et al., Contractures and hypertrophic cardiomyopathy in a novel FHL1 mutation. Ann. Neurol. 2010, 67, 136-140.
155. Lim, D. S., Roberts, R., Marian, A. J., Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: insight into the pathogenesis of phenotypes. J. Am. Coll. Cardiol. 2001, 38, 1175-1180.
156. Gaussin, V., Tomlinson, J. E., Depre, C., Engelhardt, S. et al., Common genomic response in different mouse models of β-adrenergic-induced cardiomyopathy. Circulation 2003, 108, 2926-2933.
157. Sheikh, F., Raskin, A., Chu, P.-H., Lange, S. et al., An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice. J. Clin. Invest. 2008, 118, 3870-3880.
158. Isumi, Y., Hirata, T., Saitoh, H., Miyakawa, T. et al., Transgenic overexpression of USP15 in the heart induces cardiac remodeling in mice. Biochem. Biophys. Res. Commun. 2011, 405, 216-221.
159. Chan, K. K., Wing Tsui, S. K., Lee, S. M. Y., Luk, S. C. W. et al., Molecular cloning and characterization of FHL2, a novel LIM domain protein preferentially expressed in human heart. Gene 1998, 210, 345-350.
160. Sun, J. X., Yan, G. J., Ren, A. X., You, B., Liao, J. K., FHL2/SLIM3 decreases cardiomyocyte survival by inhibitory interaction with sphingosine kinase-1. Circ. Res. 2006, 99, 468-476.
161. Lange, S., Auerbach, D., McLoughlin, P., Perriard, E. et al., Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2. J. Cell Sci. 2002, 115, 4925-4936.
162. Kimura, A., Matsumoto, Y., Hayashi, T., Inagaki, N. et al., Functional analysis of titin/connectin N2-B mutations found in cardiomyopathy. J. Muscle Res. Cell Motil. 2005, 26, 367-374.
163. Bovill, E., Westaby, S., Crisp, A., Jacobs, S., Shaw, T., Reduction of four-and-a-half LIM-protein 2 expression occurs in human left ventricular failure and leads to altered localization and reduced activity of metabolic enzymes. J. Thorac. Cardiovasc. Surg. 2009, 137, 853-861.
164. Chu, P.-H., Bardwell, W. M., Gu, Y., Ross J., Jr., Chen, J., FHL2 (SLIM3) is not essential for cardiac development and function. Mol. Cell. Biol. 2000, 20, 7460-7462.
165. Kong, Y., Shelton, J. M., Rothermel, B., Li, X. et al., Cardiac-specific LIM protein FHL2 modifies the hypertrophic response to beta-adrenergic stimulation. Circulation 2001, 103, 2731-2738.
166. Muller, J. M., Metzger, E., Greschik, H., Bosserhoff, A.-K. et al., The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus. EMBO J. 2002, 21, 736-748.
167. Purcell, N. H., Darwis, D., Bueno, O. F., Muller, J. M. et al., Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes. Mol. Cell. Biol. 2004, 24, 1081-1095.
168. Johannessen, M., Møller, S., Hansen, T., Moens, U., Ghelue, M., The multifunctional roles of the four-and-a-half-LIM only protein FHL2. Cell. Mol. Life Sci. 2006, 63, 268-284.
169. Sanguinetti, M. C., Tristani-Firouzi, M., hERG potassium channels and cardiac arrhythmia. Nature 2006, 440, 463-469.
170. Lin, J., Lin, S., Yu, X., Choy, P. C. et al., The four and a half LIM domain protein 2 interacts with and regulates the HERG channel. FEBS J. 2008, 275, 4531-4539.
171. Kovalevich, J., Tracy, B., Langford, D., PINCH: more than just an adaptor protein in cellular response. J. Cell. Physiol. 2011, 226, 940-947.
172. Liang, X., Sun, Y., Chen, J., Particularly interesting cysteine- and histidine-rich protein in cardiac development and remodeling. J. Invest. Med. 2009, 57, 842-848. 810.
173. Legate, K. R., Montanez, E., Kudlacek, O., Fussler, R., ILK, PINCH and parvin: the tIPP of integrin signalling. Nat. Rev. Mol. Cell. Biol. 2006, 7, 20-31.
174. Yang, Y. W. X., Hawkins, C. A., Chen, K., Vaynberg, J. et al., Structural basis of focal adhesion localization of LIM-only adaptor PINCH by integrin-linked kinase. J. Biol. Chem. 2008, 284, 5836-5844.
175. Meder, B., Huttner, I. G., Sedaghat-Hamedani, F., Just, S. et al., PINCH proteins regulate cardiac contractility by modulating ILK-PKB signaling. Mol. Cell. Biol. 2011, MCB. 05269-05211.
176. Chiswell, B. P., Stiegler, A. L., Razinia, Z., Nalibotski, E. et al., Structural basis of competition between PINCH1 and PINCH2 for binding to the ankyrin repeat domain of integrin-linked kinase. J. Struct. Biol. 2010, 170, 157-163.
177. Sopko, N., Qin, Y., Finan, A., Dadabayev, A. et al., Significance of thymosin β4 and implication of PINCH-1-ILK-α-parvin (PIP) complex in human dilated cardiomyopathy. PLoS One 2011, 6, e20184.
178. Liang, X., Sun, Y., Ye, M., Scimia, M. C. et al., Targeted ablation of PINCH1 and PINCH2 from murine myocardium results in dilated cardiomyopathy and early postnatal lethality. Circulation 2009, 120, 568-576.
179. Mukhopadhyay, M., Teufel, A., Yamashita, T., Agulnick, A. D. et al., Functional ablation of the mouse Ldb1 gene results in severe patterning defects during gastrulation. Development 2003, 130, 495-505.
180. Matthews, J. M., Visvader, J. E., LIM-domain-binding protein 1: a multifunctional cofactor that interacts with diverse proteins. EMBO Rep. 2003, 4, 1132-1137.
181. Ostendorff, H. P., Peirano, R. I., Peters, M. A., Schluter, A. et al., Ubiquitination-dependent cofactor exchange on LIM homeodomain transcription factors. Nature 2002, 416, 99-103.
182. Hagg, S., Skogsberg, J., Lundstrom, J., Noori, P. et al., Multi-organ expression profiling uncovers a gene module in coronary artery disease involving transendothelial migration of leukocytes and LIM domain binding 2: The Stockholm Atherosclerosis Gene Expression (STAGE) study. PLoS Genet. 2009, 5, e1000754.
183. Terasaki, A. G., Suzuki, H., Nishioka, T., Matsuzawa, E. et al., A novel LIM and SH3 protein (lasp-2) highly expressing in chicken brain. Biochem. Biophys. Res. Commun. 2004, 313, 48-54.
184. Lorenzen-Schmidt, I., McCulloch, A. D., Omens, J. H., Deficiency of actinin-associated LIM protein alters regional right ventricular function and hypertrophic remodeling. Ann. Biomed. Eng. 2005, 33, 888-896.
185. Sun, Y., Liang, X., Najafi, N., Cass, M. et al., Islet 1 is expressed in distinct cardiovascular lineages, including pacemaker and coronary vascular cells. Dev. Biol. 2007, 304, 286-296.
186. Murthy, K. K. C. K., Fortin, Y., Shen, S. H., Banville, D., ZRP-1, a zyxin-related protein, interacts with the second PDZ domain of the cytosolic protein tyrosine phosphatase hPTP1E. J. Biol. Chem. 1999, 274, 20679-20687.
187. Sharma, P., Shathasivam, T., Ignatchenko, V., Kislinger, T., Gramolini, A. O., Identification of an FHL1 protein complex containing ACTN1, ACTN4, and PDLIM1 using affinity purifications and MS-based protein-protein interaction analysis. Mol. Biosyst. 2011, 7, 1185-1196.
188. Arimura, T., Hayashi, T., Matsumoto, Y., Shibata, H. et al., Structural analysis of four and half LIM protein-2 in dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 2007, 357, 162-167.
189. Wu, C., The PINCH-ILK-parvin complexes: assembly, functions and regulation. Biochim. Biophys. Acta 2004, 1692, 55-62.
190. Braun, A., Bordoy, R., Stanchi, F., Moser, M. et al., PINCH2 is a new five LIM domain protein, homologous to PINCHand localized to focal adhesions[star, open]. Exp. Cell Res. 2003, 284, 237-248.
191. Liang, X., Zhou, Q., Li, X., Sun, Y. et al., PINCH2 plays an essential role in early murine embryonic development but is dispensable in ventricular cardiomyocytes. Mol. Cell. Biol. 2005, 25, 3056-3062.
192. Ponten, F., Schwenk, J. M., Asplund, A., Edqvist, P. H. D., The Human Protein Atlas as a proteomic resource for biomarker discovery. J. Intern. Med. 2011, 270, 428-446.
193. Ponten, F., Jirstrom, K., Uhlen, M., The Human Protein Atlas - a tool for pathology. J. Pathol. 2008, 216, 387-393.